Johnson & Johnson vs Zoetis Inc. — Stock Comparison
Johnson & Johnson (JNJ) and Zoetis Inc. (ZTS) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Zoetis Inc. narrowly edges Johnson & Johnson on Q·Score (7.3 vs 7.1 out of 10), led by Valuation (8.6 vs 7.3) and Quality (9.6 vs 9.3). Johnson & Johnson scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for ZTS (+58.3%) than for JNJ (+10.7%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
High-quality business with 68% return on equity and 28% profit margins.
⚠ limited growth momentum.
Analyst Consensus
Fundamentals
Frequently Asked Questions
JNJ vs ZTS: which stock scores better overall?
Based on Q·Score, Zoetis Inc. (ZTS) scores 7.3/10 versus Johnson & Johnson (JNJ) at 7.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: JNJ or ZTS?
Zoetis Inc. (ZTS) scores higher on Growth (5.2/10 vs 5.1/10). Johnson & Johnson reports revenue growth (9.9% YoY) while Zoetis Inc. reports (2.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is JNJ or ZTS more attractively valued?
Zoetis Inc. (ZTS) scores higher on Valuation (8.6/10 vs 7.3/10). JNJ trades at 18.0× P/E versus ZTS at 10.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about JNJ vs ZTS?
There are 23 analysts covering JNJ with a consensus price target of $252.87, and 17 analysts covering ZTS with a consensus target of $124.59. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: JNJ or ZTS?
Zoetis Inc. (ZTS) scores higher on Quality (9.6/10 vs 9.3/10). Net profit margin: JNJ at 21.8%, ZTS at 28.0%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: JNJ or ZTS?
Johnson & Johnson (JNJ) scores higher on Financial Health (6.5/10 vs 6.2/10). Market beta: JNJ at 0.26, ZTS at 0.74. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of JNJ and ZTS?
Johnson & Johnson (JNJ) has a market capitalisation of $549.8B, while Zoetis Inc. (ZTS) has a market cap of $33.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do JNJ or ZTS pay dividends?
JNJ does not currently pay a dividend, while ZTS pays a dividend yield of 2.67%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →